COURAGE Suggests Stents Do Not Benefit Stable Coronary Disease Patients

Results of the highly anticipated COURAGE trial challenge the widespread assumption that stents improve outcomes in patients with stable coronary disease, but several observers believe the findings' impact on the stent market will be modest